VG Life Sciences Inc. VGLS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

2/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

VG Life Sciences Inc. (VGLS) trades at a trailing P/E of 1.0. Trailing earnings yield is 100.00%.

Criteria proven by this page:

VALUE (100/100, Pass) — P/E is below market average (1.0); earnings yield beats bond yields (100.00%).
Trailing Earnings Yield 100.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

56/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

Proven by this page

—

FUTURE

N/A

No coverage

PAST

50/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✓

GROWTH

100/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — VGLS

Valuation Multiples

P/E (TTM)1.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings Yield100.00%

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$-0.32	$0.00	$-8.95M	-
2016	$-0.02	$0.00	$-2.08M	-
2017	$0.00	$0.00	$-268.43K	-
2018	$0.00	$0.00	$-268.43K	-
2019	$0.00	$0.00	$-268.43K	-
2020	$-0.01	$0.00	$-1.46M	-
2021	$0.00	$0.00	$-1.24M	-
2022	$0.00	$0.00	$2.12M	-
2023	$0.00	$0.00	$-2.53M	-
2024	$0.00	$0.00	$2.12M	-